Abstract BACKGROUND While most meningiomas are considered benign tumors, a subset of these tumors characterized by more aggressive clinical course and require multimodal treatment. Beyond surgical radiotherapeutic options, there no effective medical treatments available. Somatostatin receptor 2 (SSTR2) is expressed the majority meningiomas. 177Lu-DOTATATE SSTR2-targeting radionuclide that has b...